- Home
- GLPG vs WWW Comparison
GLPG vs WWW Comparison
Compare GLPG & WWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- WWW
- Stock Information
- Founded
- GLPG 1999
- WWW 1883
- Country
- GLPG Belgium
- WWW United States
- Employees
- GLPG N/A
- WWW N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- WWW Shoe Manufacturing
- Sector
- GLPG Health Care
- WWW Consumer Discretionary
- Exchange
- GLPG Nasdaq
- WWW Nasdaq
- Market Cap
- GLPG 1.8B
- WWW N/A
- IPO Year
- GLPG 2005
- WWW N/A
- Fundamental
- Price
- GLPG $26.86
- WWW $12.70
- Analyst Decision
- GLPG Sell
- WWW Strong Buy
- Analyst Count
- GLPG 4
- WWW 8
- Target Price
- GLPG $25.33
- WWW $17.38
- AVG Volume (30 Days)
- GLPG 419.6K
- WWW 1.7M
- Earning Date
- GLPG 04-23-2025
- WWW 05-08-2025
- Dividend Yield
- GLPG N/A
- WWW 3.14%
- EPS Growth
- GLPG N/A
- WWW N/A
- EPS
- GLPG N/A
- WWW 0.58
- Revenue
- GLPG $311,493,731.00
- WWW $1,755,000,000.00
- Revenue This Year
- GLPG $0.08
- WWW $4.39
- Revenue Next Year
- GLPG $0.23
- WWW $5.29
- P/E Ratio
- GLPG N/A
- WWW $21.98
- Revenue Growth
- GLPG 18.32
- WWW N/A
- 52 Week Low
- GLPG $22.36
- WWW $9.58
- 52 Week High
- GLPG $31.23
- WWW $24.64
- Technical
- Relative Strength Index (RSI)
- GLPG 67.75
- WWW 50.91
- Support Level
- GLPG $24.31
- WWW $12.15
- Resistance Level
- GLPG $24.91
- WWW $13.16
- Average True Range (ATR)
- GLPG 0.82
- WWW 0.92
- MACD
- GLPG 0.34
- WWW 0.33
- Stochastic Oscillator
- GLPG 97.49
- WWW 87.99
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.